Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004074700 | SCV003527364 | uncertain significance | not specified | 2021-08-17 | criteria provided, single submitter | clinical testing | The c.1877C>G (p.S626C) alteration is located in exon 2 (coding exon 1) of the TSHZ1 gene. This alteration results from a C to G substitution at nucleotide position 1877, causing the serine (S) at amino acid position 626 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003963722 | SCV004779267 | likely benign | TSHZ1-related disorder | 2022-09-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |